Showing results (291-300 of 343) with videos related to
Sort By:
Pageof 35
Surgery|June 30, 2023
Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer modelBenedict A Capacio, Jayanth S Shankara Narayanan, Diego A Vicente, et al.Cognition & Emotion|November 7, 2013
Are individual differences in appetitive and defensive motivation related? A psychophysiological examination in two samplesCasey Sarapas, Andrea C Katz, Brady D Nelson, et al.Journal of Translational Medicine|February 26, 2013
Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumorSteven C Katz, Rachel A Burga, Seema Naheed, et al.The American Journal of Drug and Alcohol Abuse|February 10, 2009
Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomesElizabeth C Katz, Robert P Schwartz, Stuart King, et al.Frontiers in Oncology|October 22, 2025
Pressure enabled drug delivery (PEDD) of nelitolimod increased therapeutic delivery, reduced immunosuppression, and improved efficacy in porcine and murine liver tumor modelsLauren Cournoyer, Yujia Liu, David B Jaroch, et al.Sensors (Basel, Switzerland)|June 7, 2020
Fully Automatic Landmarking of Syndromic 3D Facial Surface Scans Using 2D ImagesJordan J Bannister, Sebastian R Crites, J David Aponte, et al.Cancer Prevention Research (Philadelphia, Pa.)|April 12, 2017
Bioactivity of Oral Linaclotide in Human Colorectum for Cancer ChemopreventionDavid S Weinberg, Jieru E Lin, Nathan R Foster, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 24, 2011
Obstructive jaundice expands intrahepatic regulatory T cells, which impair liver T lymphocyte function but modulate liver cholestasis and fibrosisSteven C Katz, Kristin Ryan, Naseem Ahmed, et al.Cancer Immunology, Immunotherapy : CII|April 9, 2015
Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-TRachel A Burga, Mitchell Thorn, Gary R Point, et al.Cancer Gene Therapy|October 4, 2014
Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastasesA Saied, L Licata, R A Burga, et al.Pageof 35